Cargando…

Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey

BACKGROUND: Chronic kidney disease (CKD) is a worldwide public health problem characterized by changes in kidney structure and function, usually leading to a loss of kidney function. The identification of risk factors and management of patients with early-stage CKD may slow or prevent the progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wenbo, Li, Junqing, Zhang, Xiaohao, Zhou, Xiaomei, Xu, Junyi, Liu, Xun, Liu, Zifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254739/
https://www.ncbi.nlm.nih.gov/pubmed/32460759
http://dx.doi.org/10.1186/s12944-020-01241-7
_version_ 1783539601044930560
author Zhao, Wenbo
Li, Junqing
Zhang, Xiaohao
Zhou, Xiaomei
Xu, Junyi
Liu, Xun
Liu, Zifeng
author_facet Zhao, Wenbo
Li, Junqing
Zhang, Xiaohao
Zhou, Xiaomei
Xu, Junyi
Liu, Xun
Liu, Zifeng
author_sort Zhao, Wenbo
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) is a worldwide public health problem characterized by changes in kidney structure and function, usually leading to a loss of kidney function. The identification of risk factors and management of patients with early-stage CKD may slow or prevent the progression to end-stage renal disease. METHODS: This study used the population-based cohort database from the China Health and Nutrition Survey (CHNS). Data from 11,978 patients were collected from the 2009 to 2011 wave of the CHNS. After removing patients with missing data, we finally included 8322 participants. A cross-sectional design was used to assess the association between Apolipoprotein B (Apo-B) levels and CKD. We used overlapping covariates to develop 5 models to evaluate the odds ratios. RESULTS: Among the study participants, patients with estimated glomerular filtration rates (eGFR) < 60 ml/min/1.73m(2)were more likely to have increased Apo-B levels (> 1.2 mmol/L, 19.41%), likely to be elderly (> 65 years, 61.76%), likely to be female (61.21%), and likely to be less educated (< 6 years and > 6 & ≤12 years, 32.07 and 52.44%, respectively).The significant association between Apo-B and CKD defined by eGFR even after adjusting for confounders including demographic characteristics, nutritional status, comorbidities, biochemical indicators, and lifestyle factors. In addition, stratified analyses showed that young and middle age (< 65 years), being overweight (body mass index [BMI] > 25 kg/m(2)), and hyperuricemia were associated with higher risks of CKD stages. CONCLUSIONS: The results of this Chinese population-based study revealed a strong positive correlation between Apo-B and CKD stages. The current findings were obtained from an epidemiologic study; therefore, these data cannot directly address the mechanisms of disease progression. The underlying mechanisms require analysis in future independent validation and prospective cohort studies.
format Online
Article
Text
id pubmed-7254739
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72547392020-06-07 Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey Zhao, Wenbo Li, Junqing Zhang, Xiaohao Zhou, Xiaomei Xu, Junyi Liu, Xun Liu, Zifeng Lipids Health Dis Research BACKGROUND: Chronic kidney disease (CKD) is a worldwide public health problem characterized by changes in kidney structure and function, usually leading to a loss of kidney function. The identification of risk factors and management of patients with early-stage CKD may slow or prevent the progression to end-stage renal disease. METHODS: This study used the population-based cohort database from the China Health and Nutrition Survey (CHNS). Data from 11,978 patients were collected from the 2009 to 2011 wave of the CHNS. After removing patients with missing data, we finally included 8322 participants. A cross-sectional design was used to assess the association between Apolipoprotein B (Apo-B) levels and CKD. We used overlapping covariates to develop 5 models to evaluate the odds ratios. RESULTS: Among the study participants, patients with estimated glomerular filtration rates (eGFR) < 60 ml/min/1.73m(2)were more likely to have increased Apo-B levels (> 1.2 mmol/L, 19.41%), likely to be elderly (> 65 years, 61.76%), likely to be female (61.21%), and likely to be less educated (< 6 years and > 6 & ≤12 years, 32.07 and 52.44%, respectively).The significant association between Apo-B and CKD defined by eGFR even after adjusting for confounders including demographic characteristics, nutritional status, comorbidities, biochemical indicators, and lifestyle factors. In addition, stratified analyses showed that young and middle age (< 65 years), being overweight (body mass index [BMI] > 25 kg/m(2)), and hyperuricemia were associated with higher risks of CKD stages. CONCLUSIONS: The results of this Chinese population-based study revealed a strong positive correlation between Apo-B and CKD stages. The current findings were obtained from an epidemiologic study; therefore, these data cannot directly address the mechanisms of disease progression. The underlying mechanisms require analysis in future independent validation and prospective cohort studies. BioMed Central 2020-05-27 /pmc/articles/PMC7254739/ /pubmed/32460759 http://dx.doi.org/10.1186/s12944-020-01241-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhao, Wenbo
Li, Junqing
Zhang, Xiaohao
Zhou, Xiaomei
Xu, Junyi
Liu, Xun
Liu, Zifeng
Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey
title Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey
title_full Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey
title_fullStr Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey
title_full_unstemmed Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey
title_short Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey
title_sort apolipoprotein b and renal function: across-sectional study from the china health and nutrition survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254739/
https://www.ncbi.nlm.nih.gov/pubmed/32460759
http://dx.doi.org/10.1186/s12944-020-01241-7
work_keys_str_mv AT zhaowenbo apolipoproteinbandrenalfunctionacrosssectionalstudyfromthechinahealthandnutritionsurvey
AT lijunqing apolipoproteinbandrenalfunctionacrosssectionalstudyfromthechinahealthandnutritionsurvey
AT zhangxiaohao apolipoproteinbandrenalfunctionacrosssectionalstudyfromthechinahealthandnutritionsurvey
AT zhouxiaomei apolipoproteinbandrenalfunctionacrosssectionalstudyfromthechinahealthandnutritionsurvey
AT xujunyi apolipoproteinbandrenalfunctionacrosssectionalstudyfromthechinahealthandnutritionsurvey
AT liuxun apolipoproteinbandrenalfunctionacrosssectionalstudyfromthechinahealthandnutritionsurvey
AT liuzifeng apolipoproteinbandrenalfunctionacrosssectionalstudyfromthechinahealthandnutritionsurvey